Bollard Group LLC Grows Stock Position in Abbott Laboratories (NYSE:ABT)

Bollard Group LLC lifted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.1% in the 4th quarter, Holdings Channel.com reports. The firm owned 97,911 shares of the healthcare product maker’s stock after buying an additional 5,638 shares during the quarter. Bollard Group LLC’s holdings in Abbott Laboratories were worth $10,777,000 as […]

Related Keywords

Canada ,Lisad Earnhardt ,Roberte Funck , ,Citigroup ,Barclays ,Securities Exchange Commission ,Abbott Laboratories ,Rise Advisors ,Stuart Chaussee Associates Inc ,Cornerstone Planning Group ,Goldman Sachs Group ,Royal Bank ,Exchange Commission ,Bollard Group ,Signature Resources Capital Management ,Holdings Channel ,Wealth Management Group ,Free Report ,Resources Capital Management ,Planning Group ,Private Wealth Management Group ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Visit Holdingschannel ,Abbott Laboratories Daily ,